Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. - Wikidata - awgldk - TriplyDB

Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

http://www.wikidata.org/entity/Q33279433

about

Bone marrow derived stem cells for the treatment of end-stage liver disease Autologous bone marrow-derived cells in the treatment of liver disease patients Concise review: bone marrow autotransplants for liver disease?Systematic review: the effects of autologous stem cell therapy for patients with liver disease Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model.Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease Cellular therapy for liver disease Stem cells in clinical practice: applications and warnings.REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem Bone marrow-derived mesenchymal stem cell therapy for decompensated liver cirrhosis: a meta-analysis.Autologous bone marrow stem cells in the treatment of chronic liver disease Natural Killer Cells-Produced IFN-γ Improves Bone Marrow-Derived Hepatocytes Regeneration in Murine Liver Failure Model.Murine Sca1(+)Lin(-) bone marrow contains an endodermal precursor population that differentiates into hepatocytes.The use of cellular technologies in treatment of liver pathologies.The hematopoietic system in the context of regenerative medicine.Liver stem cells: a scientific and clinical perspective.Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy.Current status of stem cell therapy for liver diseases.Human hepatocyte transplantation: state of the art.Prospects for stem cell transplantation in the treatment of hepatic disease.Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases.Autologous bone marrow cell infusion therapy for liver cirrhosis patients.Interplay between bone marrow and liver in the pathogenesis of hepatic fibrosis.Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.Liver regenerative medicine: advances and challenges.Stem cells in liver regeneration and their potential clinical applications.Role of stem cells in repair of liver injury: experimental and clinical benefit of transferred stem cells on liver failure.Immunological basis of stem cell therapy in liver diseases.Bone marrow cell-based regenerative therapy for liver cirrhosis.Cell-based therapy approaches: the hope for incurable diseases.Use of stem cells for liver diseases-current scenario.Bone marrow stem-cell therapy for genetic and chronic liver diseases.Cell transplantation as a non-invasive strategy for treating liver fibrosis.Progress in stem cell-based therapy for liver disease.Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis.Liver stem cells derived from the bone marrow and umbilical cord blood.Hepatic regenerative potential of mouse bone marrow very small embryonic-like stem cells.Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg/Th17 cells.

P2860

Q26850412-A5C839ED-5DFC-4084-9C5E-5D6FC202AF8E Q26863284-5B505524-F0DE-4145-B232-DC6549C24F3E Q27010009-90D5C6DC-2497-4921-919E-88E3379B2053 Q27024968-216392F1-963F-4452-9241-FB7A5D2F0DD6 Q33521757-B82B9E18-2182-4ADF-9540-0D792EC1044E Q33818431-93A69DA8-4D19-444D-8ECF-8205A7E90F4C Q33887116-6FBF0BB4-0CA0-4B3B-922C-079D133CFFA0 Q33900601-32FAE937-71C1-41C4-B4A2-5E1671775241 Q34418973-C3E80653-9464-4E3B-B75F-3327A21BB95B Q34552765-7B57DC26-8DB8-436B-A18A-9B942C89120C Q35203746-B534E0ED-2EE0-4FB2-A4A7-FD6A2F588196 Q35336227-20143893-C125-45B1-B835-0F8B5A38C844 Q35550572-D2F4416F-D03C-4F1A-A289-C0D597C46CED Q36033943-EAC1DFFB-8AF7-4182-9C7C-857D3EA8D90C Q36356962-16B4634A-E2E4-403E-A9FF-00BC282D32E0 Q36379723-77916EA6-1A3A-4ADE-9858-C3315E70AEF0 Q36627127-3175C250-C98B-4D13-A489-7CA0C65F5981 Q37138044-DE5596C2-6D4E-4479-A6E3-32EFB9DDCDEB Q37352703-57C8C1DF-B288-47FC-A535-55BD11BB73FF Q37574218-F842984B-9DA5-4DA1-8D3C-E12044EC1E68 Q37599928-C63A8CFF-2F99-4F17-B4EE-146AA92EDE41 Q37768108-5D85E669-4326-4F71-A7ED-83ED96737731 Q37768554-FDA486CA-4DDB-4EE6-81A2-8FC8BD657614 Q37772790-001C9645-338C-4216-B541-637DC425C3F1 Q37992675-E1D3909E-7245-49D4-B95F-EB9291FF9388 Q38001330-5AC89AED-74BC-4214-BD37-D3136BBCE535 Q38008810-C0CF5706-D909-42B6-9126-93D707E3EABD Q38092746-E2356580-C49F-4857-9974-D5D83143AF10 Q38159684-6EA6DF82-09D9-4473-BEB2-A9FC0EE75529 Q38223210-17FDA19F-5F8F-4B4D-8122-7E3E160227F4 Q38252582-FE678D3D-60BF-40AB-AA76-C8639AF76F9A Q38265206-C850FA46-17A4-4523-8373-89BC2F986E2A Q38371445-D03B0FF1-C74D-494A-8415-2664CFF224CD Q38552426-CFF15AAE-D12F-41F1-A5C8-092D8EAD9442 Q38675565-74A45EEB-34DD-4BA5-9A8C-F8DC3CB7C998 Q38836460-15C564E3-1A19-4E41-A720-568495B988D5 Q39000508-F62BA7C3-4CA9-4802-95AE-4432A33C9813 Q39634151-C9F0F289-B0EB-4D4D-9525-0D19F0417637 Q41643401-589790BB-2175-450F-955E-D0EDB24FFA61 Q42211604-E215432E-46B4-4B1D-B991-30386207A505

P2860

Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

http://www.wikidata.org/entity/Q33279433

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Feasibility and safety of auto ...... dvanced chronic liver disease.

@ast

Feasibility and safety of auto ...... dvanced chronic liver disease.

@en

Feasibility and safety of auto ...... dvanced chronic liver disease.

@nl

type

label

Feasibility and safety of auto ...... dvanced chronic liver disease.

@ast

Feasibility and safety of auto ...... dvanced chronic liver disease.

@en

Feasibility and safety of auto ...... dvanced chronic liver disease.

@nl

prefLabel

Feasibility and safety of auto ...... dvanced chronic liver disease.

@ast

Feasibility and safety of auto ...... dvanced chronic liver disease.

@en

Feasibility and safety of auto ...... dvanced chronic liver disease.

@nl

P1433

Q33279433-5E19EBE2-8505-42E0-A369-2B4BB3C78FE7

P1476

Q33279433-5E913FFB-33F1-4DF2-88D7-EC2BA75A9B84

P2093

Q33279433-1E5BF87E-36E5-4526-ABE4-4A46938283D8

Q33279433-263DC160-17B5-44B1-9807-5B15D6B4D350

Q33279433-4E15C762-5B7A-46C1-8A17-A6C4258C7613

Q33279433-5A0D682C-21D9-46D0-8B18-533FF6CFDCD3

Q33279433-5DA40A01-D141-4049-80B6-1110B95C5D5C

Q33279433-62EBE8A6-1F86-4F55-8216-E228F393406D

Q33279433-63436715-E86D-48E7-A120-2E7F183C5472

Q33279433-A28B43C0-C1B0-454E-BD33-7F3A81802C2A

Q33279433-AC73A181-865D-42DC-B50D-DEC3E8E19099

Q33279433-CF67AECF-4602-4FDA-A24C-D92B20080C54

P2860

Q33279433-05F704A6-8859-48B0-A1C5-A70B5327B6BC

Q33279433-0605814A-8FB0-411E-96B3-44DE5AD9D83C

Q33279433-333BF754-D320-4FC0-BAFB-9891C047EEE0

Q33279433-3AE4DDD5-6887-4D54-93C7-36C22BA9F0DA

Q33279433-53D5FE83-A941-455D-8837-714242F012C0

Q33279433-646D9C7F-D497-457D-9ECB-C6B11C6FB093

Q33279433-7166A4BE-A364-476D-9E3E-F9CAD6F9B315

Q33279433-815A249B-2E0F-4514-8149-776E97A36AF2

Q33279433-9225D5EC-1DA7-4269-AF37-1C1011BEB051

Q33279433-C0787241-8D9E-4267-B813-EC12FFF8721C

P304

Q33279433-8647476A-109C-467F-8485-6981E9623991

P31

Q33279433-61D7464C-D44A-4ED8-9E0C-2AFF3D8907D1

P356

Q33279433-441AD30B-F25C-4604-9B4C-872A65196C73

P407

Q33279433-FC614D55-D480-435A-AEE7-EB1B464F0CA2

P433

Q33279433-02EB4839-3C28-4805-B974-1A877DB1DACB

P478

Q33279433-531601A1-115E-4A6D-A208-5407EC8EDE65

P50

Q33279433-7220DACF-777F-47F6-90AF-039809033A10

P577

Q33279433-ACC24043-4BAE-412F-80F1-E7559B3576FD

P5875

Q33279433-B67D5ED1-8540-4503-8D07-56DFA99E356C

P698

Q33279433-C3E0E426-0B46-4495-A598-7A6646CCE18A

P921

Q33279433-A7314A1B-2109-4E4B-A77A-B4D6301324FC

P932

Q33279433-CFF4142D-D86B-46F1-85A5-1C6BCA568603

P356

WJG.V13.I7.1067

P1433

World Journal of Gastroenterology

P1476

Feasibility and safety of auto ...... advanced chronic liver disease

@en

P2093

Andre Castro Lyra

http://www.w3.org/2001/XMLSchema#string

André Goyanna Pinheiro Silva

http://www.w3.org/2001/XMLSchema#string

Augusto César de Andrade Mota

http://www.w3.org/2001/XMLSchema#string

Eduardo Lorens Braga

http://www.w3.org/2001/XMLSchema#string

Luiz Flavio Maia da Silva

http://www.w3.org/2001/XMLSchema#string

Luiz Guilherme Costa Lyra

http://www.w3.org/2001/XMLSchema#string

Marcos Fraga Fortes

http://www.w3.org/2001/XMLSchema#string

Milena Botelho Pereira Soares

http://www.w3.org/2001/XMLSchema#string

Ricardo Ribeiro dos Santos

http://www.w3.org/2001/XMLSchema#string

Sheilla A Oliveira

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice.

Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease.

Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats

Cellular origin of regenerating parenchyma in a mouse model of severe hepatic injury.

Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence.

Development of cell therapy using autologous bone marrow cells for liver cirrhosis.

Stem cells for the treatment of liver disease.

Cell fusion is the principal source of bone-marrow-derived hepatocytes.

Transplanted bone marrow regenerates liver by cell fusion.

P304

1067-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V13.I7.1067

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6433135

http://www.w3.org/2001/XMLSchema#string

P698

17373741

http://www.w3.org/2001/XMLSchema#string

P921

P932

4146869

http://www.w3.org/2001/XMLSchema#string